Russell Kern

All filings by Russell Kern on record concern International Stem Cell Corp. In total, 5 filings cover trades dated from 29 June 2016 to 3 December 2018.

The open-market record consists of 1 sale worth €2,650, with no purchase. Other entries cover 1 share grant and 3 option exercises. Since January 2018: no purchases and 1 sale on the market.

The newest entry dates from 6 December 2018: an option exercise of €1,730, in International Stem Cell Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.